All studies
CompletedInterventional

Evaluation of antibiotic-treated catheters to prevent peritonitis associated with peritoneal dialysis

Peritoneal dialysis is a home-based treatment for kidney failure. It uses a soft plastic tube, called a catheter, to wash cleansing fluid in and out of your tummy. A common and serious problem with this treatment is peritonitis, a painful infection of the tummy lining that can lead to hospital stays or damage your dialysis tube. This UK study is testing a new type of dialysis tube. The silicone is treated with three antibiotics designed to stop germs from settling on the tube and causing infections. Researchers want to find out whether this antibiotic-treated tube is safe, comfortable, and acceptable to patients. Taking part does not require any extra hospital visits. You will receive standard dialysis care, routine check-ups, and nurse visits over six months, while completing a few brief surveys about your experience.

At a glance

Status
Completed
Sponsor
University Hospitals of Derby and Burton NHS Foundation Trust
Enrolment target
40
Start
31 Mar 2024
Estimated completion
30 Sep 2025

What is this study about?

When your kidneys stop working properly, dialysis is needed to clear waste and extra water from your blood. One common option is peritoneal dialysis. For this treatment, a doctor places a soft plastic tube into your tummy. Special cleansing fluid runs through the tube, sits in your tummy to collect waste from your body, and is then drained away. This allows many people to manage their dialysis independently at home.

The biggest challenge with peritoneal dialysis is infection. Germs can travel along the tube and reach the inside of your tummy, causing a painful condition called peritonitis. Peritonitis can make you very unwell, often needs treatment in hospital, and may mean your dialysis tube has to be removed. Right now, careful hand hygiene and standard antibiotics are the only ways to prevent these infections.

This study, called the CAP study, is testing an improved dialysis tube made with built-in antibiotics. The medicine is mixed throughout the silicone material rather than just painted on the outside. This means the tube can release a steady shield of germ-fighting medicine right where bacteria try to grow.

Researchers want to see if this treated tube is safe, comfortable, and well tolerated by patients during their usual dialysis routine. If successful, this new tube could protect patients from distressing infections, help them stay on home dialysis for longer, and save vital NHS resources.

Key takeaways

  • Tests a new peritoneal dialysis tube treated with antibiotics to prevent tummy infections.
  • Aimed at adults with kidney failure who are already planning to start peritoneal dialysis.
  • Follows your standard NHS appointment schedule with no extra hospital visits required.
  • Involves routine nurse checks, photographs of the skin site, and four short questionnaires over six months.
  • Participation is entirely voluntary and does not change your access to standard NHS care.

Who may be eligible?

You may be able to join this study if you are 18 years or older, have kidney failure, and have chosen peritoneal dialysis as your planned treatment. The study is for people having a scheduled, non-emergency procedure to place their dialysis tube.

You will not be able to take part if your tube needs to be put in as an emergency. You also cannot take part if you are pregnant, planning to become pregnant, or breastfeeding.

Because the tube contains specific medicines, you cannot join if you have a known allergy to silicone, rifampicin, triclosan, or fluoroquinolone antibiotics (such as sparfloxacin). Your kidney team will review your full medical history to confirm if the study is suitable for you.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am aged 18 or over.
  2. I have kidney failure and have chosen peritoneal dialysis as my treatment.
  3. My dialysis tube insertion is planned in advance, not an emergency.
  4. I have no known allergies to silicone or the trial antibiotics (rifampicin, triclosan, or fluoroquinolones).
  5. I am not pregnant, planning a pregnancy, or breastfeeding.
Answer every question to see your result.

What does participation involve?

If you take part, you will receive the antibiotic-treated dialysis tube during your planned hospital procedure, just as you would receive a standard tube. The study lasts for six months, and your follow-up fits entirely into normal NHS care.

You will have routine check-ups on days 0, 3, 7, and 10 after your procedure, either at the hospital or in your own home. Around day 13, you will begin your usual dialysis training. Once trained, a nurse will visit you at home to watch you perform the treatment, followed by a check-in phone call the next day and another visit seven days later.

After that, you will have standard monthly visits. At each appointment, your nurse will check your tube exit site, take a photograph of the skin, and collect routine blood samples. You will also be asked to fill in four short questionnaires about your health and how comfortable the tube feels (at the start, seven days after training, and at three and six months). If you develop an infection or need the tube taken out, the study team will test the fluid and the tube to see how the bacteria reacted.

Potential risks and benefits

The main hoped-for benefit is a lower risk of tummy infections and fewer complications that could interrupt your home dialysis. However, we cannot guarantee that the treated tube will prevent an infection for everyone. The risks are very similar to standard care, including usual risks from having a tube fitted or routine imaging scans that involve low-level radiation. There is also a small risk of an allergic reaction to the materials or medicines in the tube. Taking part is completely voluntary, and you can leave the study at any time without it affecting your ongoing NHS treatment or relationship with your healthcare team.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • University Hospitals of Derby and Burton NHS Foundation Trust
    City only
    Derby, England

Common questions

Will I need to make extra trips to the hospital?

No. The study is designed to follow your routine peritoneal dialysis schedule, using your normal hospital clinic appointments and planned home nurse visits.

How does the antibiotic tube work?

The silicone tube contains three germ-fighting medicines embedded inside it. These medicines slowly move to the surface of the tube to create a protective barrier against bacteria.

What happens if I get a tummy infection during the study?

Your kidney care team will treat the infection straight away using standard NHS care. With your permission, fluid samples will also be checked in the laboratory to help researchers learn more.

Does taking part cost anything?

No. All care, training, and study materials are provided through the NHS, funded by the National Institute for Health and Care Research.

Can I leave the study if I change my mind?

Yes. You are free to withdraw your consent at any point without giving a reason, and your medical team will continue to provide your usual kidney care.

How to find out more

Maarten Taal

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.